thioctic acid has been researched along with cardiovascular agents in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, HS; Choi, YK; Do, JY; Kim, HJ; Kim, JY; Kim, SY; Kwon, TK; Lee, HJ; Lee, IK; Lee, KU; Lee, MO; Lee, SJ; Oh, CJ; Park, IS; Park, KG | 1 |
| Baguisi, A; Beeuwkes, R; Casale, RA; Kates, SA; Lader, AS; Stewart, K | 1 |
| Olas, B | 1 |
| Ajit, M; Beeuwkes, R; Clark, G; Gibson, M; Hiremath, J; Krucoff, MW; Lader, AS; Patel, MR; Ponde, C; Ramsaran, E; Tcheng, JE | 1 |
1 review(s) available for thioctic acid and cardiovascular agents
| Article | Year |
|---|---|
Medical Functions of Hydrogen Sulfide.
Topics: Angiogenesis Inducing Agents; Cardiovascular Agents; Cysteine; Diclofenac; Disulfides; Heart; Humans; Hydrogen Sulfide; Kidney; Levodopa; Prostaglandins F, Synthetic; Reperfusion Injury; Sulfides; Thioctic Acid; Thiones; Vasodilator Agents | 2016 |
1 trial(s) available for thioctic acid and cardiovascular agents
| Article | Year |
|---|---|
SUPPORT-1 (Subjects Undergoing PCI and Perioperative Reperfusion Treatment): A Prospective, Randomized Trial of CMX-2043 in Patients Undergoing Elective Percutaneous Coronary Intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Biomarkers; Cardiovascular Agents; Coronary Artery Disease; Creatine Kinase, MB Form; Dipeptides; Double-Blind Method; Female; Humans; India; Male; Middle Aged; Myocytes, Cardiac; Necrosis; Prospective Studies; Thioctic Acid; Time Factors; Treatment Outcome; Troponin T; United States | 2020 |
2 other study(ies) available for thioctic acid and cardiovascular agents
| Article | Year |
|---|---|
α-Lipoic acid prevents neointimal hyperplasia via induction of p38 mitogen-activated protein kinase/Nur77-mediated apoptosis of vascular smooth muscle cells and accelerates postinjury reendothelialization.
Topics: Animals; Apoptosis; Cardiovascular Agents; Disease Models, Animal; Endothelial Cells; Endothelium, Vascular; Hyperplasia; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nuclear Receptor Subfamily 4, Group A, Member 1; p38 Mitogen-Activated Protein Kinases; Platelet Aggregation; Rats; Thioctic Acid; Wound Healing | 2010 |
CMX-2043 Efficacy in a Rat Model of Cardiac Ischemia-Reperfusion Injury.
Topics: Administration, Oral; Animals; Arrhythmias, Cardiac; Cardiovascular Agents; Cytoprotection; Dipeptides; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Injections, Intravenous; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Rats, Sprague-Dawley; Thioctic Acid | 2016 |